NCT05092009View on ClinicalTrials.gov

Lung Cancer Organoids and Patient Derived Tumor Xenografts

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

October 5, 2022

Primary Completion Date

April 1, 2026

Study Completion Date

April 1, 2028

Conditions
Lung Cancer
Interventions
OTHER

Tissue and blood

Tissue and blood will be derived from patient during a standard of care procedure

Trial Locations (3)

6419 PC

RECRUITING

Zuyderland Medical Center, Heerlen

6229 ET

NOT_YET_RECRUITING

Maastricht Radiation Oncology (Maastro), Maastricht

6229 HX

RECRUITING

MUMC+, Maastricht

All Listed Sponsors
lead

Maastricht Radiation Oncology

OTHER